1. Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
   Bahar Bektan Kanat et al, 2023, Annals of Geriatric Medicine and Research CrossRef
2. Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine
   Agata Nowak-Stępniowska et al, 2022, Stem Cells International CrossRef
3. Network pharmacology analysis and experimental validation to explore the mechanism of kaempferol in the treatment of osteoporosis
   Qi Dong et al, 2024, Scientific Reports CrossRef
4. Effects of 12-Week Exercise Program on Enzyme Activity of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Female Patients with Postmenopausal Osteoporosis: A Randomized Control Study
   Tamara Filipović et al, 2020, BioMed Research International CrossRef
5. Matrix Metalloproteinases in Relation to Bone Mineral Density: A Two-Sample Mendelian Randomization Study
   Xin Lv et al, 2021, Frontiers in Genetics CrossRef
6. Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation
   Mi H. Kim et al, 2022, Bone & Joint Research CrossRef
7. Protein Ca2+-Sites Prone to Sr2+ Substitution: Implications for Strontium Therapy
   Karine Mazmanian et al, 2023, The Journal of Physical Chemistry B CrossRef